145 related articles for article (PubMed ID: 22552732)
1. Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma.
Cosentino M; Palou J; Gaya JM; Breda A; Rodriguez-Faba O; Villavicencio-Mavrich H
World J Urol; 2013 Feb; 31(1):141-5. PubMed ID: 22552732
[TBL] [Abstract][Full Text] [Related]
2. Recurrent urothelial tumors following surgery for transitional cell carcinoma of the upper urinary tract.
Strong DW; Pearse HD
Cancer; 1976 Nov; 38(5):2173-83. PubMed ID: 991130
[TBL] [Abstract][Full Text] [Related]
3. Variant histology in upper tract carcinomas: Analysis of the National Cancer Database.
Song E; Suek T; Davaro F; Hamilton Z
Urol Oncol; 2023 Apr; 41(4):206.e1-206.e9. PubMed ID: 36822992
[TBL] [Abstract][Full Text] [Related]
4. French AFU Cancer Committee Guidelines - Update 2022-2024: Upper urinary tract urothelial cancer (UTUC).
Neuzillet Y; Seisen T; Traxer O; Allory Y; Audenet F; Leon P; Loriot Y; Pradère B; Roumiguié M; Xylinas E; Masson-Lecomte A; Roupret M
Prog Urol; 2022 Nov; 32(15):1164-1194. PubMed ID: 36400481
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors of bladder tumor recurrence after radical treatment of upper urinary tract cancer.
Ouanes Y; Chaker K; Yaich S; Foued D; Marrak M; Nouira Y
Tunis Med; 2023 Mar; 101(3):356-361. PubMed ID: 38263921
[TBL] [Abstract][Full Text] [Related]
6. Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes.
Linehan J; Gottlieb J; Woldu SL; Labbate C; Rose K; Sexton W; Kaimakliotis H; Jacob J; Dickstein R; Nieder A; Bjurlin M; Humphreys M; Ghodoussipor S; Quek M; O'Donnell M; Eisner BH; Feldman AS; Matin SF; Lotan Y; Murray KS
Eur Urol Focus; 2023 Nov; 9(6):1052-1058. PubMed ID: 37263827
[TBL] [Abstract][Full Text] [Related]
7. Incidence, mortality and survival of transitional cell carcinoma in the urinary system: A population-based analysis.
Tang X; Zhan X; Chen X
Medicine (Baltimore); 2023 Nov; 102(46):e36063. PubMed ID: 37986351
[TBL] [Abstract][Full Text] [Related]
8. Regional differences in upper tract urothelial carcinoma patients across the United States.
Morra S; Scheipner L; Baudo A; Jannello LMI; de Angelis M; Siech C; Goyal JA; Touma N; Tian Z; Saad F; Califano G; la Rocca R; Capece M; Shariat SF; Ahyai S; Carmignani L; de Cobelli O; Musi G; Briganti A; Chun FKH; Longo N; Karakiewicz PI
Urol Oncol; 2024 May; 42(5):162.e1-162.e10. PubMed ID: 38336499
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real-world findings from NHS England between 2013 and 2019.
Catto JWF; Mandrik O; Quayle LA; Hussain SA; McGrath J; Cresswell J; Birtle AJ; Jones RJ; Mariappan P; Makaroff LE; Knight A; Mostafid H; Chilcott J; Sasieni P; Cumberbatch M
BJU Int; 2023 Jun; 131(6):734-744. PubMed ID: 36680312
[TBL] [Abstract][Full Text] [Related]
10. First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors.
Jacob JM; Woldu SL; Linehan J; Labbate C; Rose KM; Sexton WJ; Tachibana I; Kaimakliotis H; Nieder A; Bjurlin MA; Humphreys M; Ghodoussipour SB; Quek ML; Johnson B; O'Donnell M; Eisner BH; Feldman AS; Murray KS; Matin SF; Lotan Y; Dickstein RJ
Urol Oncol; 2024 Jan; 42(1):20.e17-20.e23. PubMed ID: 37517898
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid-induced ureteric clot obstruction in a patient with urothelial cell carcinoma resulting in upper urinary tract perforation.
Maresca G; Royle J; Donaldson JF
BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35039376
[TBL] [Abstract][Full Text] [Related]
12. The ban on phenacetin is associated with changes in the incidence trends of upper-urinary tract cancers in Australia.
Antoni S; Soerjomataram I; Moore S; Ferlay J; Sitas F; Smith DP; Forman D
Aust N Z J Public Health; 2014 Oct; 38(5):455-8. PubMed ID: 25169832
[TBL] [Abstract][Full Text] [Related]
13. Urinary and household chemical exposures in pet dogs with urothelial cell carcinoma.
Braman SL; Peterson H; Elbe A; Mani E; Danielson C; Dahman C; Labadie JD; Trepanier LA
Vet Comp Oncol; 2024 Jun; 22(2):217-229. PubMed ID: 38388159
[TBL] [Abstract][Full Text] [Related]
14. Do Histology and Primary Tumor Location Influence Metastatic Patterns in Bladder Cancer?
Park HK
Curr Oncol; 2023 Oct; 30(10):9078-9089. PubMed ID: 37887556
[TBL] [Abstract][Full Text] [Related]
15. Double Primary Cancer of the Prostate and Urothelial Cancer: A Single Institution Experience.
Hoshi S; Bilim V; Hoshi K; Ogawa Y; Kato T; Urano K; Yamada T; Sakagami R; Kudo T; Numahata K; Sasagawa I
J Pers Med; 2024 May; 14(5):. PubMed ID: 38793091
[TBL] [Abstract][Full Text] [Related]
16. The UF-5000 Atyp.C parameter is an independent risk factor for bladder cancer.
Zhang T; Zhu J; Li Z; Zhao Y; Li Y; Li J; He Q; Geng Y; Lu W; Zhang L; Li Z
Sci Rep; 2024 Jun; 14(1):12659. PubMed ID: 38830942
[TBL] [Abstract][Full Text] [Related]
17. Current and Emerging Strategies to Treat Urothelial Carcinoma.
Rani B; Ignatz-Hoover JJ; Rana PS; Driscoll JJ
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835580
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines.
Zuiverloon TCM; de Jong FC; Costello JC; Theodorescu D
Bladder Cancer; 2018 Apr; 4(2):169-183. PubMed ID: 29732388
[TBL] [Abstract][Full Text] [Related]
19. Relationship between testosterone and male bladder cancer.
Tan W; Gao L; Yuan Y; Huang H; Li Y; Gou Y; Hu Z
Sci Rep; 2023 Aug; 13(1):12881. PubMed ID: 37553380
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).
Soria F; Shariat SF; Lerner SP; Fritsche HM; Rink M; Kassouf W; Spiess PE; Lotan Y; Ye D; Fernández MI; Kikuchi E; Chade DC; Babjuk M; Grollman AP; Thalmann GN
World J Urol; 2017 Mar; 35(3):379-387. PubMed ID: 27604375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
